Variant report
Variant | esv14766 |
---|---|
Chromosome Location | chr4:130126384-130137965 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:130126327..130128284-chr4:130130664..130133521,2 | MCF-7 | breast: | |
2 | chr4:130137037..130139366-chr4:130144529..130147180,2 | K562 | blood: | |
3 | chr4:130126327..130128284-chr4:130130664..130133521,2 | MCF-7 | breast: | |
4 | chr4:130129537..130132005-chr4:130135878..130137851,2 | K562 | blood: | |
5 | chr4:130129537..130132005-chr4:130135878..130137851,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575182737 | chr4:130128102-130128103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542465366 | chr4:130128114-130128115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6814153 | chr4:130128187-130128188 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs188839514 | chr4:130128200-130128201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562687214 | chr4:130128209-130128210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115581881 | chr4:130128281-130128282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541200230 | chr4:130128326-130128327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12501946 | chr4:130128335-130128336 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs574680075 | chr4:130128351-130128352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374158831 | chr4:130128359-130128360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376897732 | chr4:130128368-130128369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552216551 | chr4:130128402-130128403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17014446 | chr4:130128403-130128404 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs549666467 | chr4:130128430-130128431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78524420 | chr4:130128431-130128432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535196593 | chr4:130128443-130128444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191541290 | chr4:130128451-130128452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79387407 | chr4:130128507-130128508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4975197 | chr4:130128509-130128510 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs556540498 | chr4:130128563-130128564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138840174 | chr4:130128565-130128566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536156533 | chr4:130128587-130128588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554832599 | chr4:130128622-130128623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183400844 | chr4:130128641-130128642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142033358 | chr4:130128701-130128702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1980945 | chr4:130128812-130128813 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs568484905 | chr4:130128818-130128819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368061029 | chr4:130128923-130128924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563690544 | chr4:130128939-130128940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112471392 | chr4:130129040-130129041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187639719 | chr4:130129073-130129074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557717974 | chr4:130129096-130129097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191342964 | chr4:130129154-130129155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145719380 | chr4:130129155-130129156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528716961 | chr4:130129191-130129192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77949011 | chr4:130129256-130129257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17353486 | chr4:130129275-130129276 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs372889281 | chr4:130129282-130129283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553006187 | chr4:130129353-130129354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs138230034 | chr4:130129367-130129368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs17014451 | chr4:130129369-130129370 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs541721615 | chr4:130129379-130129380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149605291 | chr4:130129441-130129442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144342020 | chr4:130129442-130129443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372854427 | chr4:130129455-130129456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs74434257 | chr4:130129464-130129465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs57520720 | chr4:130129472-130129473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558739302 | chr4:130129480-130129481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577079643 | chr4:130129485-130129486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545554444 | chr4:130129501-130129502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:130125200-130126400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:130125200-130126400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:130125400-130126400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr4:130126200-130126400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr4:130128000-130128200 | Enhancers | Fetal Heart | heart |
6 | chr4:130128200-130129200 | Weak transcription | Fetal Heart | heart |
7 | chr4:130129200-130129600 | Enhancers | Fetal Heart | heart |
8 | chr4:130129600-130134200 | Weak transcription | Fetal Heart | heart |
9 | chr4:130134200-130136000 | Enhancers | Fetal Heart | heart |
10 | chr4:130136000-130139400 | Weak transcription | Fetal Heart | heart |